![Alain D. Baron](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alain D. Baron
No open positions remaining
Profile
Alain D.
Baron was the founder of Elcelyx Therapeutics, Inc. founded in 2010, where he held the title of President, Chief Executive Officer & Director.
Dr. Baron is also the founder of Escient Pharmaceuticals, Inc. Dr. Baron's current job is as President, Chief Executive Officer & Director at Nazura BioHealth, Inc. Dr. Baron's former jobs include President, Chief Executive Officer & Director at Essentialis, Inc. in 2012, Director at The Indiana University School of Medicine, Senior Vice President at Amylin Pharmaceuticals, Inc. from 1999 to 2007, Professor at the University of California San Diego, and Venture Partner at LSV Capital Management LLC.
Dr. Baron received his undergraduate degree from McGill University and his doctorate from Georgia Health Sciences University.
Former positions of Alain D. Baron
| Companies | Position | End |
|---|---|---|
Escient Pharmaceuticals, Inc.
 Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug discovery and development company | Chief Executive Officer | 2022-01-04 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Corporate Officer/Principal | - |
Nazura BioHealth, Inc.
 Nazura BioHealth, Inc. Part of Elcelyx Therapeutics, Inc., Nazura BioHealth, Inc. is a company that utilizes its proprietary Gut Sensory Modulation (GSM) technology platform to develop dietary supplements and medical foods. The company's focus is on addressing health and wellness concerns such as maintaining a healthy weight and maintaining healthy blood sugar levels. Nazura specializes in the physiologic release of hormones produced by the L-cells in the lower gut, including Glp-1, PYY, and . By using GSM, Nazura scientists have developed a proprietary blend of food ingredients (tastants) that augment the release of these hormones, which can affect hunger, satiety, glucose regulation, inflammatory response, and mood. The company is based in San Diego, CA. The CEO of the company is Alain D. Baron. | Chief Executive Officer | - |
The Indiana University School of Medicine
 The Indiana University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
LSV CAPITAL MANAGEMENT LLC
 LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, biotech, and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Private Equity Investor | - |
Training of Alain D. Baron
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
47
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Elcelyx Therapeutics, Inc.
 Elcelyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics based on gut sensory modulation | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgia Health Sciences University
 Georgia Health Sciences University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Essentialis, Inc.
 Essentialis, Inc. Pharmaceuticals: OtherHealth Technology Develops therapeutic products in curing metabolic diseases | Health Technology |
LSV CAPITAL MANAGEMENT LLC
LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, biotech, and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
The Indiana University School of Medicine
The Indiana University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nazura BioHealth, Inc.
Nazura BioHealth, Inc. Part of Elcelyx Therapeutics, Inc., Nazura BioHealth, Inc. is a company that utilizes its proprietary Gut Sensory Modulation (GSM) technology platform to develop dietary supplements and medical foods. The company's focus is on addressing health and wellness concerns such as maintaining a healthy weight and maintaining healthy blood sugar levels. Nazura specializes in the physiologic release of hormones produced by the L-cells in the lower gut, including Glp-1, PYY, and . By using GSM, Nazura scientists have developed a proprietary blend of food ingredients (tastants) that augment the release of these hormones, which can affect hunger, satiety, glucose regulation, inflammatory response, and mood. The company is based in San Diego, CA. The CEO of the company is Alain D. Baron. | |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug discovery and development company | Health Technology |
- Stock Market
- Insiders
- Alain D. Baron
Choose MarketScreener 
